Cambrex continues build-out at former PharmaCore site with $1m investment

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Milkos)
(Image: Getty/Milkos)

Related tags: Cambrex, Analytical testing, CMO

Cambrex is investing $1m at its High Point, NC-based site, marking the most recent in a series of investments which will see the addition of 1,300 square feet and 15 new employees.

The contract manufacturing organization​ (CMO) has announced plans to fit out 1,300 square feet of analytical laboratory space at the site. As a result, the company expects to hire nine chemical research and development scientists in addition to six analytical research and development scientists.

The expansion also will include the installation of an additional 10 ultra-performance liquid chromatography (UPLC) instruments.

Expected to be finished by the end of 2018, the expansion follows a series of investments, the most recently completed of which added 11,000 square feet of analytical laboratory space in April 2018​.

In total, Cambrex has invested more than $9m at the site, which it acquired from PharmaCore in 2016.

“Cambrex is seeing a significant increase in new projects, resulting in increased demand for analytical development capabilities within the Cambrex organization,”​ said Brian Swierenga, VP, operations and site director for Cambrex High Point in a press release.

Last month Cambrex also announced the acquisition of Avista​, a move that marked its entrance into the early stage small molecule development and testing market.

The $252m deal is expected to be completed during the fourth quarter of 2018 and will add 300 employees to Cambrex’s staff as well as four facilities.

Related products

show more

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...

Related suppliers

Follow us

Products

View more

Webinars